Compare stocks

Lonza Group AG is a Swiss multinational chemicals and biotechnology company headquartered in Basel, Switzerland. The company operates primarily in the life sciences sector, offering products and services for pharmaceutical and biotechnology companies, including custom development and manufacturing of active pharmaceutical ingredients, cell and gene therapies, and bioscience solutions. Founded in 1897, Lonza has a significant global presence with numerous production and research facilities worldwide. The company's strategic positioning lies in its comprehensive offering that supports pharmaceutical companies from early-stage development through commercialization, leveraging advanced technologies and extensive expertise in biologics.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.